Select a section from the left sidebar
Sericoside
- Family: Plantae - Combretaceae
- Kingdom: Plantae
-
Class: Saponin
- Subclass: Triterpenoid Saponin
Canonical Smiles | OC[C@H]1O[C@@H](OC(=O)[C@@]23CCC([C@H]([C@H]3C3=CC[C@H]4[C@@]([C@@]3(CC2)C)(C)CC[C@@H]2[C@]4(C)C[C@H]([C@@H]([C@]2(C)CO)O)O)O)(C)C)[C@@H]([C@H]([C@@H]1O)O)O |
---|---|
InChI | InChI=1S/C36H58O11/c1-31(2)11-13-36(30(45)47-29-26(42)25(41)24(40)20(16-37)46-29)14-12-34(5)18(23(36)28(31)44)7-8-22-32(3)15-19(39)27(43)33(4,17-38)21(32)9-10-35(22,34)6/h7,19-29,37-44H,8-17H2,1-6H3/t19-,20-,21-,22-,23-,24-,25+,26-,27+,28+,29+,32+,33-,34-,35-,36+/m1/s1 |
InChIKey | CMZFNIMQBCBHEX-JRIAKSEUSA-N |
Formula | C36H58O11 |
HBA | 11 |
HBD | 8 |
MW | 666.85 |
Rotatable Bonds | 4 |
TPSA | 197.37 |
LogP | 1.41 |
Number Rings | 6 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 47 |
Formal Charge | 0 |
Fraction CSP3 | 0.92 |
Exact Mass | 666.4 |
Number of Lipinski Rule Violations | 3 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Terminalia brownii | Combretaceae | Plantae | 1548809 |
2 | Combretum molle | Combretaceae | Plantae | 507414 |
3 | Combretum molle | Combretaceae | Plantae | 507414 |
4 | Terminalia ivorensis | Combretaceae | Plantae | 578550 |
Showing of synonyms
Sericoside
55306-04-2
4-epi-sericoside
Beta-D-Glucopyranosyl (2alpha,3beta,4beta,19alpha)-2,3,19,23-tetrahydroxyolean-12-en-28-oate
UNII-S4A9325KV4
S4A9325KV4
EINECS 259-586-3
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1S,4aR,6aR,6aS,6bR,8aR,9S,10R,11R,12aR,14bS)-1,10,11-trihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
SERICOSIDE VINYALS
DTXSID001019848
HY-N10496
AKOS040734747
DA-61620
TS-07862
CS-0568243
Q27288574
OLEAN-12-EN-28-OIC ACID, 2,3,19,23-TETRAHYDROXY, GLUCOPYRANOSYL ESTER
OLEAN-12-EN-28-OIC ACID, 2,3,19,23-TETRAHYDROXY-, .BETA.-D-GLUCOPYRANOSYL ESTER, (2.ALPHA.,3.BETA.,4.BETA.,19.ALPHA.)-
- Ponou BK, Teponno RB, et al. (2010). Dimeric antioxidant and cytotoxic triterpenoid saponins from Terminalia ivorensis A. Chev.. Phytochemistry,2010, 71(17-18), 2108-2115. [View] [PubMed]
- Asres K, Bucar F, et al. (2001). In vitro antiprotozoal activity of extract and compounds from the stem bark of Combretum molle. Phytotherapy Reseach,2001,15(7),613-617. [View] [PubMed]
- Asres K, Bucar F, et al. (2001). Investigations on antimycobacterial activity of some Ethiopian medicinal plants. Phytotherapy Research,2001,15(4),323-326. [View] [PubMed]
- Machumi F, Midiwo JO, et al. (2013). Phytochemical, antimicrobial and antiplasmodial investigations of Terminalia brownii. Natural Product Communications,2013,8(6),761-764. [View] [PubMed]
No compound-protein relationship available.
SMILES: O1CCCCC1OC(=O)C23C(CCCC3)C=4C(CC2)C5C(CC4)C6C(CC5)CCCC6
Level: 1
Mol. Weight: 666.85 g/mol
SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CCCC5
Level: 0
Mol. Weight: 666.85 g/mol
SMILES: C1CCOCC1
Level: 0
Mol. Weight: 666.85 g/mol
No bioactivities available.
Absorption
- Caco-2 (logPapp)
- -6.12
- Human Oral Bioavailability 20%
- Non-Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- -5.110
- Human Oral Bioavailability 50%
- Bioavailable
- P-Glycoprotein Inhibitor
- Inhibitor
- P-Glycoprotein Substrate
- Substrate
- Skin Permeability
- 35.92
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Non-Penetrable
- Fraction Unbound (Human)
- 0.700
- Plasma Protein Binding
- 97.08
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Non-Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Non-Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Substrate
- OATP1B1
- Inhibitor
- OATP1B3
- Non-Inhibitor
Excretion
- Clearance
- 1.030
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Safe
- Bee
- Toxic
- Bioconcentration Factor
- -5.460
- Biodegradation
- Safe
- Carcinogenesis
- Safe
- Crustacean
- Safe
- Liver Injury I (DILI)
- Toxic
- Eye Corrosion
- Safe
- Eye Irritation
- Safe
- Maximum Tolerated Dose
- 0.050
- Liver Injury II
- Safe
- hERG Blockers
- Toxic
- Daphnia Maga
- 4.950
- Micronucleos
- Toxic
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Toxic
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- -67110.210
- Rat (Acute)
- 4.230
- Rat (Chronic Oral)
- 3.550
- Fathead Minnow
- 98.540
- Respiratory Disease
- Toxic
- Skin Sensitisation
- Safe
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Toxic
- SR-p53
- Safe
General Properties
- Boiling Point
- 3962.750
- Hydration Free Energy
- -2.920
- Log(D) at pH=7.4
- 3.550
- Log(P)
- 1.77
- Log S
- -2.81
- Log(Vapor Pressure)
- -90.68
- Melting Point
- 248.67
- pKa Acid
- 5.45
- pKa Basic
- 5.78